GCG and hepatocellular carcinoma: Other studies revealed that GLP-1 analog liraglutide inhibits the growth of pancreatic cancer in animal models and hepatocellular carcinoma in HepG2 cell line (Zhao et al., 2014[29]; Krause et al., 2017[14]).